Sio Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Sio Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-26,221	Closed	-$892K	–	69
2019 Q3	$892K	Hold	26,221	–	–	0.29%	55
2019 Q2	$1.01M	Buy	26,221 +5,147	+24%	+$364K	0.24%	61
2019 Q1	$1.36M	Sell	21,074 -8,795	-29%	-$355K	0.37%	57
2018 Q4	$723K	Buy	29,869 +21,570	+260%	+$814K	0.26%	61
2018 Q3	$523K	Buy	+8,299	New	+$525K	0.18%	58

Other funds holding ACHV

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Searle & Co Greenwich, Connecticut $445M AUM 41.72% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Sio Capital Management's ACHV Position: Q4 2019 in Review

Sio Capital Management sold out of Achieve Life Sciences (ACHV) in Q4 2019, closing a stake of 26,221 shares — an estimated $892K sold.

Sio Capital Management first reported a position in ACHV in Q3 2018 and held it in 5 quarters. The position peaked at $1.36M in Q1 2019. 17 funds tracked by Wall St. Rank hold ACHV as of Q4 2019.

Sio Capital Management reported no remaining Achieve Life Sciences position as of Q4 2019 after selling out during the quarter.
Sio Capital Management sold 26,221 Achieve Life Sciences shares in Q4 2019, an estimated $892K.
Sio Capital Management first reported a position in Achieve Life Sciences in Q3 2018 and held it in 5 quarters.
Sio Capital Management's Achieve Life Sciences position peaked at $1.36M in Q1 2019.
17 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2019.

Based on Sio Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.